Evidence map›Paper›PMID 33552988›Full record

ReviewFrontiers in oncology2020

DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk.

Anna Maria Caroleo, Maria Antonietta De Ioris, Luigi Boccuto, Iside Alessi, Giada Del Baldo, Antonella Cacchione, Emanuele Agolini, Martina Rinelli, Annalisa Serra, Andrea Carai and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Rare child primary intracranial sarcoma associated with DICER1 mutation: a case report and review of the literature.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Review
  3. Cell-type Specific Alteration ofbioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Surviving childhood cancer: the hidden threat of second malignancies.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Review
  6. Article
  7. Article
  8. MosaicFrontiers in oncology · 2026
    Article
  9. Cells · 2025
    Article
  10. Cancers · 2025
    Review
  11. Article
  12. Review
  13. Approach to the Pediatric Patient With Thyroid Nodules.The Journal of clinical endocrinology and metabolism · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Intron Variant CauseHuman mutation · 2025
    Article
  18. Understanding the Dosage-Dependent Role ofInternational journal of molecular sciences · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Anna Maria CaroleoDepartment of Onco - Hematology and Cell and Gene Therapy, Bambino Gesù Pediatric Hospital (IRCCS), Roma, Italy.
Maria Antonietta De IorisDepartment of Onco - Hematology and Cell and Gene Therapy, Bambino Gesù Pediatric Hospital (IRCCS), Roma, Italy.
Luigi BoccutoJC Self Research Institute, Greenwood Genetic Center, Greenwood, SC, United States.
Iside AlessiDepartment of Onco - Hematology and Cell and Gene Therapy, Bambino Gesù Pediatric Hospital (IRCCS), Roma, Italy.
Giada Del BaldoDepartment of Onco - Hematology and Cell and Gene Therapy, Bambino Gesù Pediatric Hospital (IRCCS), Roma, Italy.
Antonella CacchioneDepartment of Onco - Hematology and Cell and Gene Therapy, Bambino Gesù Pediatric Hospital (IRCCS), Roma, Italy.
Emanuele AgoliniLaboratory of Medical Genetics, Bambino Gesù Children Hospital (IRCCS), Rome, Italy.
Martina RinelliLaboratory of Medical Genetics, Bambino Gesù Children Hospital (IRCCS), Rome, Italy.
Annalisa SerraDepartment of Onco - Hematology and Cell and Gene Therapy, Bambino Gesù Pediatric Hospital (IRCCS), Roma, Italy.
Andrea CaraiDepartment of Neuroscience, Bambino Gesù Children Hospital (IRCCS), Rome, Italy.
Angela MastronuzziDepartment of Onco - Hematology and Cell and Gene Therapy, Bambino Gesù Pediatric Hospital (IRCCS), Roma, Italy.
Bambino Gesù Children's Hospital · ITClemson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DICER1 syndrome is a rare genetic condition predisposing to hereditary cancer and caused by variants in the

Indexed as

cancer predispositioncystic nephromaDICER1pediatricPPB

Identifiers

PMID33552988
PMCPMC7859642
OpenAlexW3123080507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.